|
Market Closed -
Xetra
11:35:43 2026-10-16 EDT
|
5-day change | 1st Jan Change | ||
| 4.600 EUR | -2.13% |
|
-0.43% | -20.69% |
| 09-17 | Novo, Orbis sign up to $1.4 billion deal to develop oral drugs | RE |
| 08-19 | ORBIS AG Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other IT Services & Consulting
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 49.86M | - | - | |||
| 221B | |||||
| 203B | |||||
| 134B | |||||
| 118B | - | ||||
| 113B | - |
- Stock Market
- Stocks
- OBS Stock
- Charts ORBIS AG
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
